New eczema drug shows promise over older treatment
NCT ID NCT05969730
First seen Jan 11, 2026 · Last updated May 15, 2026 · Updated 20 times
Summary
This study tested whether baricitinib, a newer pill, works better than azathioprine, an older pill, for adults with moderate-to-severe eczema. Both were used along with steroid creams. The trial involved 40 adults and measured skin improvement after 12 weeks. The goal was to see which treatment controls eczema more effectively and safely.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Iran
Sari, Mazandaran, Iran
Conditions
Explore the condition pages connected to this study.